360 related articles for article (PubMed ID: 17457671)
1. The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.
Yu LG
Glycoconj J; 2007 Nov; 24(8):411-20. PubMed ID: 17457671
[TBL] [Abstract][Full Text] [Related]
2. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
3. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Yu LG; Andrews N; Zhao Q; McKean D; Williams JF; Connor LJ; Gerasimenko OV; Hilkens J; Hirabayashi J; Kasai K; Rhodes JM
J Biol Chem; 2007 Jan; 282(1):773-81. PubMed ID: 17090543
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the Oncofetal Thomsen-Friedenreich Antigen with Galectins in Cancer Progression and Metastasis.
Sindrewicz P; Lian LY; Yu LG
Front Oncol; 2016; 6():79. PubMed ID: 27066458
[TBL] [Abstract][Full Text] [Related]
6. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.
Bian CF; Zhang Y; Sun H; Li DF; Wang DC
PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831
[TBL] [Abstract][Full Text] [Related]
8. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
9. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
10. Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Gal beta1-3GalNac alpha-) expression seen in colon cancer.
Campbell BJ; Rowe GE; Leiper K; Rhodes JM
Glycobiology; 2001 May; 11(5):385-93. PubMed ID: 11425799
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins.
Hoffmann M; Hayes MR; Pietruszka J; Elling L
Glycoconj J; 2020 Aug; 37(4):457-470. PubMed ID: 32367478
[TBL] [Abstract][Full Text] [Related]
12. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
[TBL] [Abstract][Full Text] [Related]
13. Lectin-epithelial interactions in the human colon.
Rhodes JM; Campbell BJ; Yu LG
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1482-6. PubMed ID: 19021580
[TBL] [Abstract][Full Text] [Related]
14. The TF-antigen binding lectin from Sclerotium rolfsii inhibits growth of human colon cancer cells by inducing apoptosis in vitro and suppresses tumor growth in vivo.
Inamdar SR; Savanur MA; Eligar SM; Chachadi VB; Nagre NN; Chen C; Barclays M; Ingle A; Mahajan P; Borges A; Shastry P; Kalraiya RD; Swamy BM; Rhodes JM; Yu LG
Glycobiology; 2012 Sep; 22(9):1227-35. PubMed ID: 22653662
[TBL] [Abstract][Full Text] [Related]
15. Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.
Barrow H; Guo X; Wandall HH; Pedersen JW; Fu B; Zhao Q; Chen C; Rhodes JM; Yu LG
Clin Cancer Res; 2011 Nov; 17(22):7035-46. PubMed ID: 21933892
[TBL] [Abstract][Full Text] [Related]
16. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.
Jeschke U; Karsten U; Wiest I; Schulze S; Kuhn C; Friese K; Walzel H
Histochem Cell Biol; 2006 Oct; 126(4):437-44. PubMed ID: 16607538
[TBL] [Abstract][Full Text] [Related]
17. Peanut agglutinin appearance in the blood circulation after peanut ingestion mimics the action of endogenous galectin-3 to promote metastasis by interaction with cancer-associated MUC1.
Zhao Q; Duckworth CA; Wang W; Guo X; Barrow H; Pritchard DM; Rhodes JM; Yu LG
Carcinogenesis; 2014 Dec; 35(12):2815-21. PubMed ID: 25326505
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
19. Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas.
Flucke U; Zirbes TK; Schröder W; Mönig SP; Koch V; Schmitz K; Thiele J; Dienes HP; Hölscher AH; Baldus SE
Anticancer Res; 2001; 21(3C):2189-93. PubMed ID: 11501845
[TBL] [Abstract][Full Text] [Related]
20. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
